Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation*
暂无分享,去创建一个
Akira Nakagawara | A. Nakagawara | T. Ozaki | Hideki Yamamoto | K. Furuya | K. Ando | M. Hosoda | S. Hayashi | M. Fukuzawa | Hideki Yamamoto | Masahiro Fukuzawa | Toshinori Ozaki | Mitsuchika Hosoda | Kiyohiro Ando | Kazushige Furuya | Syunji Hayashi
[1] Yoichi Taya,et al. DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.
[2] E. Nishida,et al. Nuclear Translocation of Plk1 Mediated by Its Bipartite Nuclear Localization Signal* , 2002, The Journal of Biological Chemistry.
[3] D. Longo,et al. Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[4] A. Wilks,et al. Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Longo,et al. Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis (*) , 1995, The Journal of Biological Chemistry.
[6] J. Yuan,et al. Polo-like kinase, a novel marker for cellular proliferation. , 1997, The American journal of pathology.
[7] Yoichi Taya,et al. ATM associates with and phosphorylates p53: mapping the region of interaction , 1999, Nature Genetics.
[8] T. Karn,et al. Induction and down-regulation of PLK, a human serine/threonine kinase expressed in proliferating cells and tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Glover,et al. Polo kinase: the choreographer of the mitotic stage? , 1996, The Journal of cell biology.
[11] P. Friedman,et al. Wild-type p53 activates transcription in vitro , 1992, Nature.
[12] E. Nishida,et al. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase , 2001, Nature.
[13] E. Nishida,et al. Plk1 promotes nuclear translocation of human Cdc25C during prophase , 2002, EMBO reports.
[14] V. Rotter,et al. Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis , 1990, Molecular and cellular biology.
[15] D. Longo,et al. Cell Cycle Regulation of the Human Polo-like Kinase (PLK) Promoter* , 1997, The Journal of Biological Chemistry.
[16] C. Prives,et al. The p53 pathway , 1999, The Journal of pathology.
[17] Min Gyu Lee,et al. Glucose Metabolism in Cancer , 2003, Journal of Biological Chemistry.
[18] Jürgen Bereiter-Hahn,et al. Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. , 2002, Journal of the National Cancer Institute.
[19] D. Slamon,et al. prk, a Cytokine-inducible Human Protein Serine/Threonine Kinase Whose Expression Appears to be Down-regulated in Lung Carcinomas* , 1996, The Journal of Biological Chemistry.
[20] Takao Hayakawa,et al. Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter , 2002, Molecular and Cellular Biology.
[21] J. Winkles,et al. Identification by Targeted Differential Display of an Immediate Early Gene Encoding a Putative Serine/Threonine Kinase(*) , 1995, The Journal of Biological Chemistry.
[22] U. Moll,et al. ΔNp73, A Dominant-Negative Inhibitor of Wild-type p53 and TAp73, Is Up-regulated in Human Tumors , 2002, The Journal of experimental medicine.
[23] H. Lane,et al. Cell-cycle control: POLO-like kinases join the outer circle. , 1997, Trends in cell biology.
[24] E. Nishida,et al. Identification of a Consensus Motif for Plk (Polo-like Kinase) Phosphorylation Reveals Myt1 as a Plk1 Substrate* , 2003, Journal of Biological Chemistry.
[25] David J Weber,et al. Inhibition of p53 Transcriptional Activity by the S100B Calcium-binding Protein* , 2001, The Journal of Biological Chemistry.
[26] W. Dai,et al. Reactive Oxygen Species-induced Phosphorylation of p53 on Serine 20 Is Mediated in Part by Polo-like Kinase-3* , 2001, The Journal of Biological Chemistry.
[27] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[28] F. Kashanchi,et al. Phosphorylation of p53 Serine 15 Increases Interaction with CBP* , 1998, The Journal of Biological Chemistry.
[29] Delin Chen,et al. Negative Control of p53 by Sir2α Promotes Cell Survival under Stress , 2001, Cell.
[30] C. Dang,et al. Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins. , 1989, The Journal of biological chemistry.
[31] R. Medema,et al. Inhibition of Polo-like Kinase-1 by DNA Damage Occurs in an ATM- or ATR-dependent Fashion* , 2001, The Journal of Biological Chemistry.
[32] C. von Ilberg,et al. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. , 1999, Cancer research.
[33] E. Nigg. Polo-like kinases: positive regulators of cell division from start to finish. , 1998, Current opinion in cell biology.
[34] Xiaoqi Liu,et al. Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] Y Taya,et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.
[36] Guillermina Lozano,et al. Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation , 2003, Cell.
[37] W. Kaelin,et al. MDM2 Suppresses p73 Function without Promoting p73 Degradation , 1999, Molecular and Cellular Biology.
[38] R. Erikson,et al. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] C. McGowan,et al. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways , 2002, Oncogene.
[40] R. Medema,et al. Polo-like kinase-1 is a target of the DNA damage checkpoint , 2000, Nature Cell Biology.
[41] A. Bräuninger,et al. Identification and functional characterization of the human and murine polo-like kinase (Plk) promoter. , 1995, Oncogene.
[42] Hirofumi Tanaka,et al. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 , 1997, FEBS letters.
[43] R. Mantovani,et al. The molecular biology of the CCAAT-binding factor NF-Y. , 1999, Gene.
[44] A. Levine,et al. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex , 1986, Journal of virology.
[45] J. Bereiter-Hahn,et al. Cooperative phosphorylation including the activity of polo-like kinase 1 regulates the subcellular localization of cyclin B1 , 2002, Oncogene.
[46] Kyung S. Lee,et al. Essential Function of the Polo Box of Cdc5 in Subcellular Localization and Induction of Cytokinetic Structures , 2000, Molecular and Cellular Biology.
[47] W. Dai,et al. Plk3 Functionally Links DNA Damage to Cell Cycle Arrest and Apoptosis at Least in Part via the p53 Pathway* , 2001, The Journal of Biological Chemistry.
[48] B. Vogelstein,et al. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.
[49] D. Longo,et al. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. , 1997, Biochemical and biophysical research communications.
[50] A. Nakagawara,et al. Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function* , 2002, The Journal of Biological Chemistry.
[51] Y. Li,et al. PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer , 2000, Genes, chromosomes & cancer.
[52] J. Maller,et al. Purification and cloning of a protein kinase that phosphorylates and activates the polo-like kinase Plx1. , 1998, Science.
[53] D. Glover,et al. Polo-like kinases: a team that plays throughout mitosis. , 1998, Genes & development.
[54] A. Nakagawara,et al. A product of DAN, a novel candidate tumour suppressor gene, is secreted into culture medium and suppresses DNA synthesis. , 1997, European journal of cancer.
[55] H. Ackermann,et al. Prognostic significance of polo-like kinase (PLK) expression in non-small cell lung cancer , 1997, Oncogene.
[56] K. Vousden. Activation of the p53 tumor suppressor protein. , 2002, Biochimica et biophysica acta.
[57] B. Li,et al. Human Prk Is a Conserved Protein Serine/Threonine Kinase Involved in Regulating M Phase Functions* , 1997, The Journal of Biological Chemistry.
[58] E. Nigg,et al. Cell Cycle Regulation of the Activity and Subcellular Localization of Plk1, a Human Protein Kinase Implicated in Mitotic Spindle Function Finally, Genetic Studies Performed with Fungi and Flies Have Identified Multiple Protein Kinases , 1995 .
[59] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[60] K. Strebhardt,et al. PLK (polo‐like kinase), a new prognostic marker for oropharyngeal carcinomas , 2000, International journal of cancer.
[61] J. Bartek,et al. Cell cycle analysis and chromosomal localization of human Plk1, a putative homologue of the mitotic kinases Drosophila polo and Saccharomyces cerevisiae Cdc5. , 1994, Journal of cell science.
[62] T. Stokke,et al. Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1 , 2003, Oncogene.
[63] S. Loibl,et al. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells , 2002, Oncogene.
[64] Chin-Yo Lin,et al. Functional studies on the role of the C-terminal domain of mammalian polo-like kinase , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[65] S. Um,et al. Identification and Characterization of HIPK2 Interacting with p73 and Modulating Functions of the p53 Familyin Vivo * , 2002, The Journal of Biological Chemistry.
[66] Y. Sánchez,et al. Incomplete cytokinesis and induction of apoptosis by overexpression of the mammalian polo-like kinase, Plk3. , 2000, Cancer research.